when will glp 1 become generic GLP-1 2.0: Where the Next Wave of Value Be Created Looming GLP-1 drug patent expirations
Description
Macroalbuminuria occurred less (2.2%) in exenatide group compared to placebo group (2.5%) [HR 0.87 (95% CI: 0.701.07)]
While these drugs have benefits, there is a serious risk of low blood sugar for those with type 1 diabetes who take a GLP-1 agonist together with insulin
This means that GLP-1 could help treat osteoporosis and similar bone issues, particularly in people with T2DM

The most common side effects are nausea, mild vomiting, constipation, or diarrhea particularly during dose escalation

8 , 806813 (2019) J.M
